The probabilityofthefdaapprovingadrugis50

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: erval = mean return + or - 2 standard errors, so lower bound = .311 - 2 × .0542 = .2026 or 20.26% upper bound = .311 + 2 × .0542 = .4194 or 41.94% Diff: 3 Topic: 10.3 Historical Returns of Stocks and Bonds Skill: Analytical 10.4 The Historical Tradeoff Between Risk and Return Use the table for the question(s) below. Consider the following average annual returns: Investment Average Return Small Stocks 23.2% S&P 500 13.2% Corporate Bonds 7.5% Treasury Bonds 6.2% Treasury Bills 4.8% 14) What is the excess return for the portfolio of small stocks? A) 10.0% B) 15.7% C) 18.4% D) 17.0% Answer: C Explanation: A) B) C) Average Return - Tbill Investment Average Return Return Small Stocks 23.2% 18.40% S&P 500 13.2% 8.40% Corporate Bonds 7.5% 2.70% Treasury Bonds 6.2% 1.40% Treasury Bills 4.8% 0.0% D) Diff: 1 Topic: 10.4 The Historical Tradeoff Between Risk and Return Skill: Analytical Use the information for the question(s) below. Big Cure and Little Cure are both pharmaceutical companies. Big Cure presently has a potential ʺblockbusterʺ drug before the Food and Drug Administration (FDA) waiting for approval. If approved, Big Cureʹs blockbuster drug will produce $1 billion in net income for Big Cure. Little Cure has 10 separate less important drugs before the FDA waiting for approval. If approved, each of Little Cureʹs drugs would produce $100 million in net income for Little Cure. The probability...
View Full Document

{[ snackBarMessage ]}

Ask a homework question - tutors are online